The aim of this study is compare the reversal of rocuronium induced neuromuscular blockade in morbidly obese patients using three doses of sugammadex; based on ideal body weight, adjusted body weight, and actual body weight.

The aim of this study is compare the reversal of rocuronium induced neuromuscular blockade in morbidly obese patients using three doses of sugammadex; based on ideal body weight, adjusted body weight, and actual body weight. Reversal Time: time from administration of Sugammadex to train of four (TOF) ratio ≥ 0.9 will be used as primary outcome.

Time need for extubation (time from administration of sugammadex to extubation), and duration of stay in post anesthesia care unit (PACU), will be used as secondary outcome.

Inclusion Criteria:

• patients older than 18 years and under 45 years,
• body mass index ≥ 40 kg/m2, with indication of bariatric surgery

Exclusion Criteria:

• Patients with comorbid including: neuromuscular disease, renal impairment, and patients with difficult airway were excluded from this study.